Pharma Mar S.A.
Biopharmaceutical company developing oncology treatments from marine sources.
PHM | MC
Overview
Corporate Details
- ISIN(s):
- ES0169501022 (+1 more)
- LEI:
- 959800QWKZ45ZQC2AV58
- Country:
- Spain
- Address:
- Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo
- Website:
- https://pharmamar.com/en/
- Sector:
- Manufacturing
Description
Pharma Mar S.A. is a biopharmaceutical company specializing in the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to develop innovative therapies for cancer, with a particular focus on rare tumors. Its integrated R&D pipeline spans from the exploration of marine invertebrates to the marketing of approved drugs. The company maintains an extensive collection of over 500,000 marine samples, which serves as the foundation for its drug discovery programs. Key commercialized products include Yondelis® (trabectedin) for advanced soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-10-26 17:38 |
La Sociedad publica información financiera correspondiente al tercer trimestre …
|
Spanish | 823.0 KB | ||
| 2023-10-04 18:37 |
La Sociedad informa de las operaciones de adquisición de acciones propias en el…
|
Spanish | 1018.9 KB | ||
| 2023-09-06 17:41 |
La Sociedad informa de las operaciones de adquisición de acciones propias en el…
|
Spanish | 323.2 KB | ||
| 2023-07-27 17:56 |
La Sociedad anuncia iniciar la adquisición de acciones propias al amparo de la …
|
Spanish | 37.3 KB | ||
| 2023-07-19 15:42 |
La Sociedad anuncia que su socio Immedica Pharma AB ha recibido la aprobación c…
|
Spanish | 109.2 KB | ||
| 2023-07-11 13:15 |
La Sociedad anuncia que su socio, Lotus Pharmaceutical CO., Ltd. ha recibido la…
|
Spanish | 111.2 KB | ||
| 2023-07-05 17:42 |
La Sociedad remite detalle de las operaciones del Contrato de Liquidez comprend…
|
Spanish | 127.5 KB | ||
| 2023-06-15 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2023-06-06 14:26 |
La Sociedad anuncia junto con su socio Luye Pharma Group Ltd. la aceptación de …
|
Spanish | 180.4 KB | ||
| 2023-05-31 13:51 |
La Sociedad informa sobre el pago del dividendo
|
Spanish | 34.6 KB | ||
| 2023-05-30 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2023-05-12 00:00 |
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | ||
| 2023-05-11 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2023-05-08 00:00 |
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2023-05-04 09:04 |
Nota de prensa informando sobre el reclutamiento del primer paciente en un nuev…
|
Spanish | 92.5 KB |
Automate Your Workflow. Get a real-time feed of all Pharma Mar S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Pharma Mar S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Pharma Mar S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
